Tyler Dylan-hyde - Net Worth and Insider Trading
Tyler Dylan-hyde Net Worth
The estimated net worth of Tyler Dylan-hyde is at least $1 Million dollars as of 2024-11-13. Tyler Dylan-hyde is the Chief Legal Officer of CRISPR Therapeutics AG and owns about 25,204 shares of CRISPR Therapeutics AG (CRSP) stock worth over $1 Million. Details can be seen in Tyler Dylan-hyde's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tyler Dylan-hyde has not made any transactions after 2018-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tyler Dylan-hyde
Tyler Dylan-hyde Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tyler Dylan-hyde owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Tyler Dylan-hyde’s form 4 insider trades.
Insider Ownership Summary of Tyler Dylan-hyde
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-01-16 | Chief Legal Officer |
Tyler Dylan-hyde Latest Holdings Summary
Tyler Dylan-hyde currently owns a total of 1 stock. Tyler Dylan-hyde owns 25,204 shares of CRISPR Therapeutics AG (CRSP) as of January 16, 2018, with a value of $1 Million.
Latest Holdings of Tyler Dylan-hyde
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-01-16 | 25,204 | 50.73 | 1,278,599 |
Holding Weightings of Tyler Dylan-hyde
Tyler Dylan-hyde Form 4 Trading Tracker
According to the SEC Form 4 filings, Tyler Dylan-hyde has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 66,000 shares on January 16, 2018, which brought Tyler Dylan-hyde around $2 Million.
Insider Trading History of Tyler Dylan-hyde
- 1
Tyler Dylan-hyde Trading Performance
Tyler Dylan-hyde Ownership Network
Ownership Network List of Tyler Dylan-hyde
Ownership Network Relation of Tyler Dylan-hyde
Tyler Dylan-hyde Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Tyler Dylan-hyde is the Chief Legal Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include General Counsel and Secretary James R. Kasinger , Chief Business Officer Samarth Kulkarni , and Chief Financial Officer Raju Prasad .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Tyler Dylan-hyde made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 179,630 shares made by Samarth Kulkarni , a net sale of 6,949 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 5,382 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 5,382 shares. During the past 18 months, 193,469 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 193,469 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Tyler Dylan-hyde Mailing Address
Above is the net worth, insider trading, and ownership report for Tyler Dylan-hyde. You might contact Tyler Dylan-hyde via mailing address: C/o Crispr Therapeutics Ag, 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
